STOCK TITAN

Kestra Medical: Brian Daniel Webster proposes 15K-share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. (KMTS) officer and director Brian Daniel Webster gave notice of a proposed sale of 15,000 common shares, with an aggregate market value of $426,920.72 and an approximate sale date of November 18, 2026. The notice lists July 21, 2026 as the date of plan adoption or instruction if relying on Rule 10b5-1. It also reports prior sales during the past three months, including 51,900 shares sold on August 4, 2026 for gross proceeds of $1,272,585.45.

Proposed sale shares 15,000 shares Approximate sale date November 18, 2026
Aggregate market value $426,920.72 For the proposed sale of 15,000 common shares
Shares outstanding 59,561,795 shares Common shares outstanding reported in the securities information
Shares acquired 15,000 shares Performance stock issuance on July 14, 2026
Prior sale shares 51,900 shares Sale reported for August 4, 2026
Prior sale gross proceeds $1,272,585.45 Sale reported for August 4, 2026
Rule 10b5-1 regulatory
"if relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Performance Stock Issuance financial
"Nature of Acquisition Transaction"
equity compensation plan financial
"Granted as part of issuer equity compensation plan"
A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KMTS shares did Brian Daniel Webster propose to sell?

Brian Daniel Webster, an officer and director, reported a proposed sale of 15,000 common shares, with an aggregate market value of $426,920.72 and an approximate sale date of November 18, 2026.

How did Brian Daniel Webster acquire the KMTS shares covered by the notice?

The shares were acquired from Kestra on July 14, 2026 through a Performance Stock Issuance granted as part of the issuer's equity compensation plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading